Evidence map›Paper›PMID 42688324›Full record

ArticleCureus2026

Metastatic Melanoma Presenting As Small Bowel Obstruction.

Amanda Ruci, Sarah M Chan, Carolyn K Kan, Chris Fagel, Jetrina Maque

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amanda RuciInternal Medicine, University of California, Los Angeles, Los Angeles, USA.
Sarah M ChanInternal Medicine, University of California Los Angeles, Los Angeles, USA.
Carolyn K KanInternal Medicine, West Los Angeles VA, Los Angeles, USA.
Chris FagelInternal Medicine, University of California Los Angeles, Los Angeles, USA.
Jetrina MaqueInternal Medicine, University of California Los Angeles, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic melanoma to the gastrointestinal (GI) system is a known, though overall rare, phenomenon. Typically, symptomatic presentations from GI metastases are uncommon and often nonspecific, contributing to delayed diagnosis. We present the case of a male patient with a history of cutaneous melanoma treated with wide local excision one and a half years earlier, who presents to the emergency department with presyncope, acute nausea, vomiting, and melena. Initial workup revealed a five-point hemoglobin drop. Computed tomography (CT) of the abdomen and pelvis showed a high-grade small bowel obstruction with a soft tissue mass at the transition point. The patient underwent a diagnostic laparoscopy, small bowel resection, and lymph node dissection. Histopathology and immunohistochemical markers confirmed the diagnosis of malignant melanoma, which, along with the patient's history of cutaneous melanoma, favored a metastatic etiology. This case demonstrates the need to maintain a high index of suspicion for metastatic melanoma in patients with a prior history of cutaneous melanoma, especially for those presenting with bowel obstruction or obscure GI symptoms. Surgical resection is the mainstay of therapy and can be both diagnostic and therapeutic.

Indexed as

gi metastasismalignant small bowel obstructionmetastatic cutaneous melanomametastatic melanomasmall bowel obstruction

Identifiers

PMID42688324
PMCPMC13534796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.